

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.59363183 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 4.95924223 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.95924223 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.95924223 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.95924223 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 4.95924223 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 4.95924223 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.54695648 |
| 9 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.13191988 |
| 10 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.02078459 |
| 11 | positive regulation of interferon-alpha production (GO:0032727) | 3.96627186 |
| 12 | cellular extravasation (GO:0045123) | 3.94917173 |
| 13 | regulation of interferon-alpha production (GO:0032647) | 3.89187129 |
| 14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.88382381 |
| 15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.88382381 |
| 16 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.78162695 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.75779545 |
| 18 | tolerance induction (GO:0002507) | 3.73624953 |
| 19 | macrophage activation involved in immune response (GO:0002281) | 3.70248067 |
| 20 | response to muramyl dipeptide (GO:0032495) | 3.62411584 |
| 21 | detection of molecule of bacterial origin (GO:0032490) | 3.60764020 |
| 22 | detection of other organism (GO:0098543) | 3.57764289 |
| 23 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.52121917 |
| 24 | neutrophil activation involved in immune response (GO:0002283) | 3.51796137 |
| 25 | regulation of gamma-delta T cell activation (GO:0046643) | 3.48822428 |
| 26 | negative regulation of cell killing (GO:0031342) | 3.40000903 |
| 27 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.40000903 |
| 28 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.34653378 |
| 29 | immunoglobulin mediated immune response (GO:0016064) | 3.32982838 |
| 30 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.31753479 |
| 31 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.27714543 |
| 32 | germinal center formation (GO:0002467) | 3.23939221 |
| 33 | positive thymic T cell selection (GO:0045059) | 3.22296304 |
| 34 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.20703506 |
| 35 | positive regulation of interferon-beta production (GO:0032728) | 3.20631817 |
| 36 | detection of bacterium (GO:0016045) | 3.17854298 |
| 37 | response to peptidoglycan (GO:0032494) | 3.17574802 |
| 38 | detection of external biotic stimulus (GO:0098581) | 3.17148833 |
| 39 | response to type I interferon (GO:0034340) | 3.14949998 |
| 40 | myeloid dendritic cell differentiation (GO:0043011) | 3.10992458 |
| 41 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.08714011 |
| 42 | response to host immune response (GO:0052572) | 3.08714011 |
| 43 | leukocyte aggregation (GO:0070486) | 3.08495533 |
| 44 | type I interferon signaling pathway (GO:0060337) | 3.07938475 |
| 45 | cellular response to type I interferon (GO:0071357) | 3.07938475 |
| 46 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.05646845 |
| 47 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.05370839 |
| 48 | NIK/NF-kappaB signaling (GO:0038061) | 3.04199873 |
| 49 | granulocyte activation (GO:0036230) | 3.03083483 |
| 50 | T cell migration (GO:0072678) | 2.99465444 |
| 51 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.99439774 |
| 52 | natural killer cell mediated immunity (GO:0002228) | 2.98492271 |
| 53 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.98492271 |
| 54 | positive regulation of interleukin-12 production (GO:0032735) | 2.97901257 |
| 55 | neutrophil activation (GO:0042119) | 2.97334215 |
| 56 | myeloid dendritic cell activation (GO:0001773) | 2.96364924 |
| 57 | response to host (GO:0075136) | 2.95519076 |
| 58 | response to host defenses (GO:0052200) | 2.95519076 |
| 59 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.95519076 |
| 60 | negative thymic T cell selection (GO:0045060) | 2.93046997 |
| 61 | detection of biotic stimulus (GO:0009595) | 2.91907920 |
| 62 | negative T cell selection (GO:0043383) | 2.91655536 |
| 63 | embryonic process involved in female pregnancy (GO:0060136) | 2.89927772 |
| 64 | negative regulation of B cell proliferation (GO:0030889) | 2.89758722 |
| 65 | interferon-gamma production (GO:0032609) | 2.88738534 |
| 66 | microglial cell activation (GO:0001774) | 2.87417194 |
| 67 | positive regulation of B cell differentiation (GO:0045579) | 2.87353105 |
| 68 | regulation of mast cell degranulation (GO:0043304) | 2.87109494 |
| 69 | myeloid cell activation involved in immune response (GO:0002275) | 2.85518304 |
| 70 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.85106188 |
| 71 | positive regulation of mast cell activation (GO:0033005) | 2.83697307 |
| 72 | positive regulation of heat generation (GO:0031652) | 2.79084711 |
| 73 | cytokine secretion (GO:0050663) | 2.78089590 |
| 74 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.77589083 |
| 75 | regulation of leukocyte degranulation (GO:0043300) | 2.77139958 |
| 76 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.76347009 |
| 77 | negative regulation of interleukin-12 production (GO:0032695) | 2.75258456 |
| 78 | natural killer cell differentiation (GO:0001779) | 2.73087742 |
| 79 | regulation of interleukin-12 production (GO:0032655) | 2.72803259 |
| 80 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.71831980 |
| 81 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.71831980 |
| 82 | positive regulation of interleukin-2 production (GO:0032743) | 2.70104481 |
| 83 | I-kappaB phosphorylation (GO:0007252) | 2.69522717 |
| 84 | leukocyte cell-cell adhesion (GO:0007159) | 2.68684999 |
| 85 | thymic T cell selection (GO:0045061) | 2.68666861 |
| 86 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.68666377 |
| 87 | positive regulation of T cell cytokine production (GO:0002726) | 2.68585710 |
| 88 | negative regulation of T cell mediated immunity (GO:0002710) | 2.66824915 |
| 89 | hepatocyte apoptotic process (GO:0097284) | 2.66538583 |
| 90 | histone H3-K36 demethylation (GO:0070544) | 2.66439187 |
| 91 | macrophage activation (GO:0042116) | 2.66156458 |
| 92 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.65312361 |
| 93 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.64738957 |
| 94 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.64233837 |
| 95 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.64230037 |
| 96 | response to laminar fluid shear stress (GO:0034616) | 2.63387542 |
| 97 | regulation of B cell differentiation (GO:0045577) | 2.62290405 |
| 98 | B cell receptor signaling pathway (GO:0050853) | 2.61876499 |
| 99 | regulation of fever generation (GO:0031620) | 2.61291573 |
| 100 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.61101225 |
| 101 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.60445387 |
| 102 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.60397119 |
| 103 | positive regulation of antigen processing and presentation (GO:0002579) | 2.58518595 |
| 104 | defense response to protozoan (GO:0042832) | 2.58367289 |
| 105 | T cell selection (GO:0045058) | 2.58250738 |
| 106 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.58032910 |
| 107 | B cell mediated immunity (GO:0019724) | 2.57845167 |
| 108 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.56931001 |
| 109 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.55843364 |
| 110 | regulation of chronic inflammatory response (GO:0002676) | 2.55592523 |
| 111 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.55473541 |
| 112 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.55202985 |
| 113 | regulation of mast cell activation (GO:0033003) | 2.54397831 |
| 114 | T-helper 1 type immune response (GO:0042088) | 2.54356492 |
| 115 | B cell homeostasis (GO:0001782) | 2.53320019 |
| 116 | respiratory burst (GO:0045730) | 2.53234771 |
| 117 | response to interleukin-15 (GO:0070672) | 2.52857223 |
| 118 | cellular response to interferon-gamma (GO:0071346) | 2.51434473 |
| 119 | regulation of tolerance induction (GO:0002643) | 2.51262627 |
| 120 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.51115924 |
| 121 | positive regulation of leukocyte degranulation (GO:0043302) | 2.50616448 |
| 122 | positive regulation of isotype switching (GO:0045830) | 2.50491609 |
| 123 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.50044819 |
| 124 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.49947790 |
| 125 | dendritic cell differentiation (GO:0097028) | 2.48954121 |
| 126 | regulation of T cell tolerance induction (GO:0002664) | 2.48913887 |
| 127 | natural killer cell activation (GO:0030101) | 2.48649941 |
| 128 | response to protozoan (GO:0001562) | 2.48390560 |
| 129 | myeloid leukocyte activation (GO:0002274) | 2.48236628 |
| 130 | negative regulation of interleukin-17 production (GO:0032700) | 2.48130813 |
| 131 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.47594494 |
| 132 | cellular response to zinc ion (GO:0071294) | 2.47332889 |
| 133 | monocyte chemotaxis (GO:0002548) | 2.47266370 |
| 134 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.46900188 |
| 135 | regulation of interferon-beta production (GO:0032648) | 2.46873604 |
| 136 | positive T cell selection (GO:0043368) | 2.46578236 |
| 137 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.43613531 |
| 138 | dendritic cell chemotaxis (GO:0002407) | 2.42980598 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.39090636 |
| 2 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.98029111 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.43045731 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.24089795 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.14247902 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.90232487 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.81680121 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.40236723 |
| 9 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.33443394 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.26929058 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.23032604 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.15726265 |
| 13 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.12163820 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.85672072 |
| 15 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.84729283 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.67614476 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.67082122 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.64051427 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.54715958 |
| 20 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.49712947 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.44009777 |
| 22 | MYB_26560356_Chip-Seq_TH2_Human | 2.31966793 |
| 23 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.29109766 |
| 24 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.28315468 |
| 25 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.18890991 |
| 26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.09655714 |
| 27 | * MYC_22102868_ChIP-Seq_BL_Human | 2.06648070 |
| 28 | * MAF_26560356_Chip-Seq_TH1_Human | 2.06206237 |
| 29 | MYB_26560356_Chip-Seq_TH1_Human | 1.95065275 |
| 30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.90902545 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.86402343 |
| 32 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.80155704 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.79927902 |
| 34 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.79425092 |
| 35 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.75760119 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.73997683 |
| 37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.71754715 |
| 38 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.71049783 |
| 39 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.63798351 |
| 40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.60926682 |
| 41 | UTX_26944678_Chip-Seq_JUKART_Human | 1.59772680 |
| 42 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.51498703 |
| 43 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.48535623 |
| 44 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.43874767 |
| 45 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.43847930 |
| 46 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.41620814 |
| 47 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.41612819 |
| 48 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.40866559 |
| 49 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.38919523 |
| 50 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.38112819 |
| 51 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.37498676 |
| 52 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.33101173 |
| 53 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.31908075 |
| 54 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.27872019 |
| 55 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.27344800 |
| 56 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22981544 |
| 57 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.18877140 |
| 58 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15623677 |
| 59 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.15158731 |
| 60 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.14312407 |
| 61 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.14312407 |
| 62 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.14312407 |
| 63 | MAF_26560356_Chip-Seq_TH2_Human | 1.13782667 |
| 64 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11474933 |
| 65 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11128180 |
| 66 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10776920 |
| 67 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.10464965 |
| 68 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09899482 |
| 69 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.09256088 |
| 70 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07998168 |
| 71 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.07752925 |
| 72 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.07465461 |
| 73 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.07421276 |
| 74 | GATA3_26560356_Chip-Seq_TH2_Human | 1.06493609 |
| 75 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.06281291 |
| 76 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.05246826 |
| 77 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05106060 |
| 78 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05090408 |
| 79 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01241722 |
| 80 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.01156863 |
| 81 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.01156863 |
| 82 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98713254 |
| 83 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.95175038 |
| 84 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.93739479 |
| 85 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.93687240 |
| 86 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92800073 |
| 87 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.92446247 |
| 88 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91592645 |
| 89 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.90816760 |
| 90 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.89533249 |
| 91 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86428232 |
| 92 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.85807266 |
| 93 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.85487735 |
| 94 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.84606867 |
| 95 | GATA1_19941826_ChIP-Seq_K562_Human | 0.84194351 |
| 96 | GATA2_19941826_ChIP-Seq_K562_Human | 0.84184919 |
| 97 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.84115375 |
| 98 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.83856269 |
| 99 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83643539 |
| 100 | * TFEB_21752829_ChIP-Seq_HELA_Human | 0.83547529 |
| 101 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.83483497 |
| 102 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.82658022 |
| 103 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.79265674 |
| 104 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79083551 |
| 105 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78445724 |
| 106 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.78232506 |
| 107 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.76765414 |
| 108 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.76471281 |
| 109 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.75890522 |
| 110 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.74554667 |
| 111 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.74211273 |
| 112 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.73368519 |
| 113 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72317750 |
| 114 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.71974275 |
| 115 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.71897515 |
| 116 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.71892143 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.63352080 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.62138202 |
| 3 | MP0003436_decreased_susceptibility_to | 3.07979805 |
| 4 | MP0003300_gastrointestinal_ulcer | 2.98136890 |
| 5 | MP0001790_abnormal_immune_system | 2.85015014 |
| 6 | MP0005387_immune_system_phenotype | 2.85015014 |
| 7 | MP0000685_abnormal_immune_system | 2.82161643 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.77602277 |
| 9 | MP0009785_altered_susceptibility_to | 2.71482225 |
| 10 | MP0001800_abnormal_humoral_immune | 2.67424348 |
| 11 | MP0005671_abnormal_response_to | 2.66832311 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.53518415 |
| 13 | MP0006082_CNS_inflammation | 2.45306132 |
| 14 | MP0002419_abnormal_innate_immunity | 2.42329865 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.41369121 |
| 16 | MP0002723_abnormal_immune_serum | 2.38949371 |
| 17 | MP0005025_abnormal_response_to | 2.32307328 |
| 18 | MP0004510_myositis | 2.30890052 |
| 19 | MP0001819_abnormal_immune_cell | 2.20098292 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.18864761 |
| 21 | MP0003724_increased_susceptibility_to | 2.18747962 |
| 22 | MP0008057_abnormal_DNA_replication | 2.18164722 |
| 23 | MP0004947_skin_inflammation | 2.06699512 |
| 24 | MP0002166_altered_tumor_susceptibility | 1.99462935 |
| 25 | MP0002405_respiratory_system_inflammati | 1.97125884 |
| 26 | MP0009278_abnormal_bone_marrow | 1.95570879 |
| 27 | MP0010352_gastrointestinal_tract_polyps | 1.94291504 |
| 28 | MP0010155_abnormal_intestine_physiology | 1.93979259 |
| 29 | MP0005076_abnormal_cell_differentiation | 1.92109635 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.92051376 |
| 31 | MP0002006_tumorigenesis | 1.87017665 |
| 32 | MP0003763_abnormal_thymus_physiology | 1.86696904 |
| 33 | MP0001853_heart_inflammation | 1.84810261 |
| 34 | MP0005451_abnormal_body_composition | 1.84632845 |
| 35 | MP0002398_abnormal_bone_marrow | 1.82468346 |
| 36 | MP0003448_altered_tumor_morphology | 1.78982153 |
| 37 | MP0000716_abnormal_immune_system | 1.73923451 |
| 38 | MP0000569_abnormal_digit_pigmentation | 1.72604042 |
| 39 | MP0001533_abnormal_skeleton_physiology | 1.72246846 |
| 40 | MP0001845_abnormal_inflammatory_respons | 1.67126385 |
| 41 | * MP0005464_abnormal_platelet_physiology | 1.59231595 |
| 42 | MP0009333_abnormal_splenocyte_physiolog | 1.53839280 |
| 43 | MP0010307_abnormal_tumor_latency | 1.50707213 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.50328466 |
| 45 | MP0005397_hematopoietic_system_phenotyp | 1.50328466 |
| 46 | MP0000689_abnormal_spleen_morphology | 1.48411288 |
| 47 | MP0008004_abnormal_stomach_pH | 1.46809110 |
| 48 | MP0002722_abnormal_immune_system | 1.46382348 |
| 49 | MP0000858_altered_metastatic_potential | 1.45737198 |
| 50 | MP0001873_stomach_inflammation | 1.45229150 |
| 51 | MP0008260_abnormal_autophagy | 1.45204011 |
| 52 | MP0004808_abnormal_hematopoietic_stem | 1.44889535 |
| 53 | MP0003656_abnormal_erythrocyte_physiolo | 1.42100709 |
| 54 | MP0003566_abnormal_cell_adhesion | 1.41792045 |
| 55 | MP0002429_abnormal_blood_cell | 1.41585291 |
| 56 | MP0003172_abnormal_lysosome_physiology | 1.39874599 |
| 57 | MP0002998_abnormal_bone_remodeling | 1.34573709 |
| 58 | MP0005310_abnormal_salivary_gland | 1.34513080 |
| 59 | MP0002254_reproductive_system_inflammat | 1.31083629 |
| 60 | MP0005167_abnormal_blood-brain_barrier | 1.27182324 |
| 61 | MP0000703_abnormal_thymus_morphology | 1.26731623 |
| 62 | MP0000465_gastrointestinal_hemorrhage | 1.25237377 |
| 63 | MP0002396_abnormal_hematopoietic_system | 1.23876494 |
| 64 | MP0008469_abnormal_protein_level | 1.20455499 |
| 65 | MP0003453_abnormal_keratinocyte_physiol | 1.19861777 |
| 66 | MP0002933_joint_inflammation | 1.19736410 |
| 67 | MP0003091_abnormal_cell_migration | 1.16524201 |
| 68 | MP0004381_abnormal_hair_follicle | 1.16410896 |
| 69 | MP0003705_abnormal_hypodermis_morpholog | 1.15204182 |
| 70 | MP0003866_abnormal_defecation | 1.14159082 |
| 71 | MP0000343_altered_response_to | 1.12341776 |
| 72 | MP0001851_eye_inflammation | 1.12293499 |
| 73 | MP0003191_abnormal_cellular_cholesterol | 1.11827402 |
| 74 | MP0009764_decreased_sensitivity_to | 1.10322188 |
| 75 | MP0004264_abnormal_extraembryonic_tissu | 1.08052722 |
| 76 | MP0000490_abnormal_crypts_of | 1.07042676 |
| 77 | MP0003075_altered_response_to | 1.04726647 |
| 78 | MP0009840_abnormal_foam_cell | 1.04714190 |
| 79 | MP0004883_abnormal_blood_vessel | 1.03140075 |
| 80 | MP0005023_abnormal_wound_healing | 1.02478440 |
| 81 | MP0003828_pulmonary_edema | 1.01637386 |
| 82 | MP0003221_abnormal_cardiomyocyte_apopto | 0.99605150 |
| 83 | MP0005166_decreased_susceptibility_to | 0.96747920 |
| 84 | MP0000604_amyloidosis | 0.95832128 |
| 85 | MP0000015_abnormal_ear_pigmentation | 0.92320882 |
| 86 | MP0003045_fibrosis | 0.91801280 |
| 87 | MP0002277_abnormal_respiratory_mucosa | 0.90317325 |
| 88 | MP0003690_abnormal_glial_cell | 0.87435428 |
| 89 | MP0002138_abnormal_hepatobiliary_system | 0.86992620 |
| 90 | MP0002877_abnormal_melanocyte_morpholog | 0.85438103 |
| 91 | MP0000249_abnormal_blood_vessel | 0.84896429 |
| 92 | MP0005390_skeleton_phenotype | 0.83757567 |
| 93 | MP0000733_abnormal_muscle_development | 0.83227608 |
| 94 | MP0005075_abnormal_melanosome_morpholog | 0.80983466 |
| 95 | MP0003183_abnormal_peptide_metabolism | 0.80557304 |
| 96 | MP0005164_abnormal_response_to | 0.80192721 |
| 97 | MP0005409_darkened_coat_color | 0.78803739 |
| 98 | MP0005621_abnormal_cell_physiology | 0.78046077 |
| 99 | MP0001881_abnormal_mammary_gland | 0.77144118 |
| 100 | MP0005174_abnormal_tail_pigmentation | 0.73724982 |
| 101 | MP0009763_increased_sensitivity_to | 0.72057449 |
| 102 | MP0003795_abnormal_bone_structure | 0.71819147 |
| 103 | MP0001915_intracranial_hemorrhage | 0.71309106 |
| 104 | MP0006054_spinal_hemorrhage | 0.69620214 |
| 105 | MP0000371_diluted_coat_color | 0.68598710 |
| 106 | MP0002019_abnormal_tumor_incidence | 0.67520644 |
| 107 | MP0000767_abnormal_smooth_muscle | 0.67158992 |
| 108 | MP0005666_abnormal_adipose_tissue | 0.67121285 |
| 109 | MP0002136_abnormal_kidney_physiology | 0.66738459 |
| 110 | MP0000627_abnormal_mammary_gland | 0.63729872 |
| 111 | MP0010234_abnormal_vibrissa_follicle | 0.62513005 |
| 112 | MP0002009_preneoplasia | 0.61558145 |
| 113 | MP0001216_abnormal_epidermal_layer | 0.61521856 |
| 114 | MP0004185_abnormal_adipocyte_glucose | 0.60841184 |
| 115 | MP0000609_abnormal_liver_physiology | 0.58522863 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.32027079 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.77444559 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.44282812 |
| 4 | Myositis (HP:0100614) | 4.16386099 |
| 5 | Orchitis (HP:0100796) | 4.05344385 |
| 6 | Optic neuritis (HP:0100653) | 4.02992938 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 4.02992938 |
| 8 | Recurrent fungal infections (HP:0002841) | 3.82422536 |
| 9 | Autoimmune thrombocytopenia (HP:0001973) | 3.71013899 |
| 10 | Recurrent viral infections (HP:0004429) | 3.69018731 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 3.66807118 |
| 12 | Stomatitis (HP:0010280) | 3.60158820 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.56333742 |
| 14 | Abnormality of macrophages (HP:0004311) | 3.55829306 |
| 15 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.47351129 |
| 16 | Increased cerebral lipofuscin (HP:0011813) | 3.41071219 |
| 17 | Vasculitis (HP:0002633) | 3.13006643 |
| 18 | Hematochezia (HP:0002573) | 3.09001336 |
| 19 | T lymphocytopenia (HP:0005403) | 3.03374416 |
| 20 | Abnormality of T cell number (HP:0011839) | 3.03170120 |
| 21 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.02898786 |
| 22 | Cellulitis (HP:0100658) | 3.00465243 |
| 23 | Chronic otitis media (HP:0000389) | 2.99646033 |
| 24 | Recurrent skin infections (HP:0001581) | 2.95244278 |
| 25 | Interstitial pulmonary disease (HP:0006530) | 2.90924535 |
| 26 | Arterial thrombosis (HP:0004420) | 2.89751953 |
| 27 | Prolonged bleeding time (HP:0003010) | 2.85305626 |
| 28 | Pulmonary infiltrates (HP:0002113) | 2.83805658 |
| 29 | Gingivitis (HP:0000230) | 2.79525749 |
| 30 | Myocardial infarction (HP:0001658) | 2.76012519 |
| 31 | Persistence of primary teeth (HP:0006335) | 2.71988421 |
| 32 | Chronic obstructive pulmonary disease (HP:0006510) | 2.71374092 |
| 33 | Obstructive lung disease (HP:0006536) | 2.71374092 |
| 34 | Recurrent bronchitis (HP:0002837) | 2.69180525 |
| 35 | Recurrent cutaneous fungal infections (HP:0011370) | 2.63975640 |
| 36 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.63975640 |
| 37 | Vacuolated lymphocytes (HP:0001922) | 2.62682382 |
| 38 | Abnormality of the fingertips (HP:0001211) | 2.61913851 |
| 39 | Abnormal platelet volume (HP:0011876) | 2.57960587 |
| 40 | Epistaxis (HP:0000421) | 2.56395433 |
| 41 | Osteomyelitis (HP:0002754) | 2.52296856 |
| 42 | Pustule (HP:0200039) | 2.52226792 |
| 43 | Meningitis (HP:0001287) | 2.50107922 |
| 44 | Nasal polyposis (HP:0100582) | 2.49458660 |
| 45 | Periodontitis (HP:0000704) | 2.48613797 |
| 46 | Chest pain (HP:0100749) | 2.48141406 |
| 47 | Keratoconjunctivitis sicca (HP:0001097) | 2.44802388 |
| 48 | Disinhibition (HP:0000734) | 2.44754400 |
| 49 | Papillary thyroid carcinoma (HP:0002895) | 2.44306120 |
| 50 | Abnormality of T cells (HP:0002843) | 2.43696731 |
| 51 | Leukocytosis (HP:0001974) | 2.43343277 |
| 52 | Spontaneous hematomas (HP:0007420) | 2.42287337 |
| 53 | Thyroiditis (HP:0100646) | 2.39020311 |
| 54 | Basal ganglia calcification (HP:0002135) | 2.37696124 |
| 55 | Hemoptysis (HP:0002105) | 2.37475706 |
| 56 | Inflammation of the large intestine (HP:0002037) | 2.37239182 |
| 57 | Encephalitis (HP:0002383) | 2.37024613 |
| 58 | Colitis (HP:0002583) | 2.35548981 |
| 59 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.32909247 |
| 60 | IgA deficiency (HP:0002720) | 2.32138379 |
| 61 | Osteolytic defects of the hand bones (HP:0009699) | 2.31425594 |
| 62 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.31425594 |
| 63 | Abnormality of the nasal mucosa (HP:0000433) | 2.31252482 |
| 64 | Tetraparesis (HP:0002273) | 2.30648827 |
| 65 | Thick nail (HP:0001805) | 2.30538509 |
| 66 | Increased mean platelet volume (HP:0011877) | 2.29967884 |
| 67 | IgM deficiency (HP:0002850) | 2.29116828 |
| 68 | Increased density of long bones (HP:0006392) | 2.26515391 |
| 69 | Gastrointestinal inflammation (HP:0004386) | 2.25841832 |
| 70 | Spinal cord lesions (HP:0100561) | 2.25544466 |
| 71 | Syringomyelia (HP:0003396) | 2.25544466 |
| 72 | Keratoconjunctivitis (HP:0001096) | 2.21513692 |
| 73 | Subacute progressive viral hepatitis (HP:0006572) | 2.21342046 |
| 74 | Increased IgE level (HP:0003212) | 2.17719160 |
| 75 | Eosinophilia (HP:0001880) | 2.17286199 |
| 76 | Prostate neoplasm (HP:0100787) | 2.16749427 |
| 77 | Loss of speech (HP:0002371) | 2.16245572 |
| 78 | Fatigue (HP:0012378) | 2.14952598 |
| 79 | Urticaria (HP:0001025) | 2.14767827 |
| 80 | Combined immunodeficiency (HP:0005387) | 2.14374877 |
| 81 | Severe combined immunodeficiency (HP:0004430) | 2.12387015 |
| 82 | Chronic diarrhea (HP:0002028) | 2.08872046 |
| 83 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.08155759 |
| 84 | Amaurosis fugax (HP:0100576) | 2.06431044 |
| 85 | Lymphopenia (HP:0001888) | 2.06225050 |
| 86 | Premature loss of primary teeth (HP:0006323) | 2.04880990 |
| 87 | Systemic lupus erythematosus (HP:0002725) | 2.04422090 |
| 88 | Slow saccadic eye movements (HP:0000514) | 2.03235790 |
| 89 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.02514950 |
| 90 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.01392135 |
| 91 | Abnormality of T cell physiology (HP:0011840) | 2.00973513 |
| 92 | Gastrointestinal stroma tumor (HP:0100723) | 2.00403325 |
| 93 | Abnormality of eosinophils (HP:0001879) | 1.98627668 |
| 94 | Amyloidosis (HP:0011034) | 1.98577532 |
| 95 | Gastrointestinal infarctions (HP:0005244) | 1.98555987 |
| 96 | Emphysema (HP:0002097) | 1.98101848 |
| 97 | Autoimmune hemolytic anemia (HP:0001890) | 1.96941161 |
| 98 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.96188346 |
| 99 | Recurrent pneumonia (HP:0006532) | 1.96087569 |
| 100 | Spondylolisthesis (HP:0003302) | 1.94325038 |
| 101 | Esophageal varix (HP:0002040) | 1.93898515 |
| 102 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.92394532 |
| 103 | Gingival bleeding (HP:0000225) | 1.91592402 |
| 104 | Anorexia (HP:0002039) | 1.90826217 |
| 105 | Gangrene (HP:0100758) | 1.90205486 |
| 106 | Panhypogammaglobulinemia (HP:0003139) | 1.87980161 |
| 107 | Dysostosis multiplex (HP:0000943) | 1.87001791 |
| 108 | Abnormality of glycolipid metabolism (HP:0010969) | 1.86528426 |
| 109 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.86528426 |
| 110 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.86528426 |
| 111 | Sepsis (HP:0100806) | 1.85528423 |
| 112 | Arthralgia (HP:0002829) | 1.85173450 |
| 113 | Petechiae (HP:0000967) | 1.85027448 |
| 114 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.84542599 |
| 115 | Bladder carcinoma (HP:0002862) | 1.84489822 |
| 116 | Bladder neoplasm (HP:0009725) | 1.84489822 |
| 117 | Pulmonary embolism (HP:0002204) | 1.84450922 |
| 118 | Agammaglobulinemia (HP:0004432) | 1.84312593 |
| 119 | Skin ulcer (HP:0200042) | 1.84217124 |
| 120 | Granulocytopenia (HP:0001913) | 1.84059705 |
| 121 | Axonal loss (HP:0003447) | 1.83998773 |
| 122 | Absent frontal sinuses (HP:0002688) | 1.83825231 |
| 123 | Viral hepatitis (HP:0006562) | 1.83725930 |
| 124 | Conjunctival telangiectasia (HP:0000524) | 1.83369746 |
| 125 | Hypergammaglobulinemia (HP:0010702) | 1.83341693 |
| 126 | Purpura (HP:0000979) | 1.83314704 |
| 127 | Abnormality of B cell number (HP:0010975) | 1.82059271 |
| 128 | B lymphocytopenia (HP:0010976) | 1.82059271 |
| 129 | Glomerulopathy (HP:0100820) | 1.77923886 |
| 130 | Verrucae (HP:0200043) | 1.74890050 |
| 131 | Papilloma (HP:0012740) | 1.74890050 |
| 132 | Abnormality of the common coagulation pathway (HP:0010990) | 1.74421366 |
| 133 | Deep philtrum (HP:0002002) | 1.73269131 |
| 134 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.72159011 |
| 135 | Leiomyosarcoma (HP:0100243) | 1.70115914 |
| 136 | Uterine leiomyosarcoma (HP:0002891) | 1.70115914 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 3.93689522 |
| 2 | MAP4K1 | 3.37459176 |
| 3 | MAP3K14 | 3.24856031 |
| 4 | TXK | 3.06258915 |
| 5 | TYK2 | 2.87623978 |
| 6 | TBK1 | 2.82024901 |
| 7 | JAK3 | 2.81961241 |
| 8 | IRAK3 | 2.37040360 |
| 9 | JAK1 | 2.29088446 |
| 10 | IKBKE | 2.27286725 |
| 11 | BMPR2 | 2.17009034 |
| 12 | STK10 | 2.09572785 |
| 13 | TRIB3 | 2.08856873 |
| 14 | CDK12 | 1.99514191 |
| 15 | FGFR3 | 1.91606075 |
| 16 | IKBKB | 1.88731574 |
| 17 | EPHB1 | 1.88439653 |
| 18 | TAOK3 | 1.79179214 |
| 19 | FGFR4 | 1.76964424 |
| 20 | KIT | 1.74828846 |
| 21 | BRD4 | 1.74205045 |
| 22 | ITK | 1.72791471 |
| 23 | ZAP70 | 1.70539008 |
| 24 | IRAK4 | 1.69700184 |
| 25 | CHUK | 1.62856229 |
| 26 | TGFBR2 | 1.56389648 |
| 27 | BLK | 1.51739667 |
| 28 | PIM1 | 1.49535992 |
| 29 | MAP3K10 | 1.48424928 |
| 30 | RPS6KA4 | 1.47764385 |
| 31 | EPHA3 | 1.45611538 |
| 32 | ERN1 | 1.45441377 |
| 33 | RIPK4 | 1.44207210 |
| 34 | KSR2 | 1.42116337 |
| 35 | HCK | 1.40335953 |
| 36 | CSK | 1.35082792 |
| 37 | YES1 | 1.31716849 |
| 38 | EIF2AK3 | 1.31625673 |
| 39 | CDK6 | 1.29859907 |
| 40 | MST4 | 1.29775942 |
| 41 | MAP3K1 | 1.29127965 |
| 42 | TEC | 1.28326389 |
| 43 | EEF2K | 1.25498682 |
| 44 | MAP3K2 | 1.24441101 |
| 45 | BTK | 1.22682593 |
| 46 | LRRK2 | 1.22550185 |
| 47 | MARK3 | 1.21560067 |
| 48 | LCK | 1.19961511 |
| 49 | PBK | 1.18985845 |
| 50 | PTK6 | 1.14280103 |
| 51 | PIM2 | 1.13593216 |
| 52 | BMX | 1.12552142 |
| 53 | PKN2 | 1.11895871 |
| 54 | SYK | 1.11833973 |
| 55 | GRK6 | 1.11830123 |
| 56 | NEK9 | 1.11085343 |
| 57 | JAK2 | 1.10764568 |
| 58 | IRAK2 | 1.06378985 |
| 59 | CSF1R | 1.05783780 |
| 60 | PIK3CG | 1.05042121 |
| 61 | TAOK2 | 1.04656077 |
| 62 | ACVR1B | 0.97704907 |
| 63 | MAP2K3 | 0.97131776 |
| 64 | NLK | 0.96851731 |
| 65 | RIPK1 | 0.96613648 |
| 66 | STK4 | 0.94561147 |
| 67 | STK3 | 0.93653284 |
| 68 | CAMK1D | 0.91946801 |
| 69 | SIK1 | 0.91924025 |
| 70 | MAP3K3 | 0.84650672 |
| 71 | NEK6 | 0.82017251 |
| 72 | PDGFRB | 0.80311215 |
| 73 | LYN | 0.79721103 |
| 74 | DMPK | 0.78533989 |
| 75 | SGK2 | 0.77278052 |
| 76 | KSR1 | 0.75795369 |
| 77 | MATK | 0.74036268 |
| 78 | CDK4 | 0.73522306 |
| 79 | EGFR | 0.72753284 |
| 80 | MAP3K13 | 0.71452898 |
| 81 | MAPK7 | 0.70720324 |
| 82 | CDK9 | 0.70171764 |
| 83 | ALK | 0.68730311 |
| 84 | SCYL2 | 0.68034692 |
| 85 | RET | 0.62831747 |
| 86 | SMG1 | 0.61667193 |
| 87 | SGK3 | 0.61245738 |
| 88 | MOS | 0.60069899 |
| 89 | PRKCQ | 0.59745620 |
| 90 | SIK2 | 0.58610875 |
| 91 | IRAK1 | 0.58462022 |
| 92 | PDPK1 | 0.57971827 |
| 93 | TRPM7 | 0.57320237 |
| 94 | MAP3K8 | 0.57148676 |
| 95 | RAF1 | 0.56405370 |
| 96 | STK24 | 0.56262072 |
| 97 | ABL1 | 0.55354094 |
| 98 | MAP3K5 | 0.55331417 |
| 99 | TTN | 0.55121181 |
| 100 | MAP3K6 | 0.54023685 |
| 101 | PDGFRA | 0.51691822 |
| 102 | CAMK1G | 0.51434163 |
| 103 | GSK3A | 0.48901862 |
| 104 | FLT3 | 0.47833365 |
| 105 | MELK | 0.47346827 |
| 106 | MAPK12 | 0.46220130 |
| 107 | NME2 | 0.46181729 |
| 108 | CDC42BPA | 0.43896100 |
| 109 | TAOK1 | 0.42390365 |
| 110 | MAPKAPK2 | 0.41751484 |
| 111 | RPS6KA5 | 0.41731647 |
| 112 | CLK1 | 0.40825997 |
| 113 | MARK2 | 0.40441447 |
| 114 | DYRK1B | 0.39784765 |
| 115 | HIPK2 | 0.39593811 |
| 116 | RPS6KL1 | 0.37697087 |
| 117 | RPS6KC1 | 0.37697087 |
| 118 | MTOR | 0.37620758 |
| 119 | INSR | 0.37531383 |
| 120 | PRKCH | 0.37387699 |
| 121 | IGF1R | 0.37075638 |
| 122 | NUAK1 | 0.36830397 |
| 123 | FGR | 0.36319657 |
| 124 | PDK1 | 0.36108947 |
| 125 | FES | 0.35542727 |
| 126 | TGFBR1 | 0.34053087 |
| 127 | MST1R | 0.34047532 |
| 128 | SIK3 | 0.32195232 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.76161746 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.71177957 |
| 3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.54287138 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.48640521 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.31934458 |
| 6 | Measles_Homo sapiens_hsa05162 | 2.24223316 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.11749834 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.04450752 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.00794516 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 1.99599888 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.89496667 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.88474935 |
| 13 | Legionellosis_Homo sapiens_hsa05134 | 1.86745622 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.85956828 |
| 15 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.82884346 |
| 16 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.82402866 |
| 17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.80856362 |
| 18 | Malaria_Homo sapiens_hsa05144 | 1.74841307 |
| 19 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.73338268 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.71260049 |
| 21 | Influenza A_Homo sapiens_hsa05164 | 1.67289375 |
| 22 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.67282121 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.64789099 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.59348002 |
| 25 | Pertussis_Homo sapiens_hsa05133 | 1.54267349 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.53210986 |
| 27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.46226778 |
| 28 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.43619432 |
| 29 | Apoptosis_Homo sapiens_hsa04210 | 1.43537755 |
| 30 | Asthma_Homo sapiens_hsa05310 | 1.43350295 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.40255634 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.37737555 |
| 33 | Viral myocarditis_Homo sapiens_hsa05416 | 1.37277093 |
| 34 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.36134113 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.32572898 |
| 36 | Hepatitis B_Homo sapiens_hsa05161 | 1.32407358 |
| 37 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.29676833 |
| 38 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.29351587 |
| 39 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.27314422 |
| 40 | Lysosome_Homo sapiens_hsa04142 | 1.24027342 |
| 41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.22887274 |
| 42 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.22693575 |
| 43 | Shigellosis_Homo sapiens_hsa05131 | 1.21731648 |
| 44 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.17298922 |
| 45 | Salmonella infection_Homo sapiens_hsa05132 | 1.17167404 |
| 46 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.13242445 |
| 47 | Hepatitis C_Homo sapiens_hsa05160 | 1.13094075 |
| 48 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.07897958 |
| 49 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.07640643 |
| 50 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.04957967 |
| 51 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.03450273 |
| 52 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.00432062 |
| 53 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.98255436 |
| 54 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.96118367 |
| 55 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.94508586 |
| 56 | Thyroid cancer_Homo sapiens_hsa05216 | 0.94367103 |
| 57 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.93242237 |
| 58 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.91454089 |
| 59 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.91414871 |
| 60 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.87927238 |
| 61 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.85765929 |
| 62 | HTLV-I infection_Homo sapiens_hsa05166 | 0.84810576 |
| 63 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.81286334 |
| 64 | Bladder cancer_Homo sapiens_hsa05219 | 0.80628706 |
| 65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.80029404 |
| 66 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.79683317 |
| 67 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.78539878 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.77756824 |
| 69 | Amoebiasis_Homo sapiens_hsa05146 | 0.76088547 |
| 70 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.75626967 |
| 71 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75128894 |
| 72 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.73922781 |
| 73 | * Platelet activation_Homo sapiens_hsa04611 | 0.73582724 |
| 74 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.72977195 |
| 75 | Phagosome_Homo sapiens_hsa04145 | 0.71625163 |
| 76 | Other glycan degradation_Homo sapiens_hsa00511 | 0.71234115 |
| 77 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.70845611 |
| 78 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.70112064 |
| 79 | Insulin resistance_Homo sapiens_hsa04931 | 0.68849664 |
| 80 | Prostate cancer_Homo sapiens_hsa05215 | 0.66944591 |
| 81 | Adherens junction_Homo sapiens_hsa04520 | 0.66064752 |
| 82 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.64739761 |
| 83 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.64303309 |
| 84 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.63708039 |
| 85 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.61868828 |
| 86 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.61354016 |
| 87 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60207978 |
| 88 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.59095740 |
| 89 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.59057073 |
| 90 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.58793215 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58626600 |
| 92 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.58488112 |
| 93 | Colorectal cancer_Homo sapiens_hsa05210 | 0.58070965 |
| 94 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57907553 |
| 95 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55733799 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.53800209 |
| 97 | Endocytosis_Homo sapiens_hsa04144 | 0.52389947 |
| 98 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.52346221 |
| 99 | Focal adhesion_Homo sapiens_hsa04510 | 0.51931488 |
| 100 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.51679925 |
| 101 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.50535798 |
| 102 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.48012017 |
| 103 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.46637429 |
| 104 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.45904142 |
| 105 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45573360 |
| 106 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.45410205 |
| 107 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44648065 |
| 108 | Endometrial cancer_Homo sapiens_hsa05213 | 0.43876537 |
| 109 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39814776 |
| 110 | Glioma_Homo sapiens_hsa05214 | 0.38743827 |
| 111 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.38584748 |
| 112 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.38491253 |
| 113 | Mineral absorption_Homo sapiens_hsa04978 | 0.38324188 |
| 114 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.37691897 |

